Mortality Determinants in Children with Biliary Atresia Awaiting Liver Transplantation

Space: StayCurrentMD Author: J Pediatr. 2020 Sep 17:S0022-3476(20)31130-6. doi: 10.1016/j.jpeds.2020.09.005. Online ahead of print. (Ziogas IA, Ye F, Zhao Z, Cao S, Rauf MA, Izzy M, Matsuoka LK, Gillis LA, Alexopoulos SP.- curated by SCHCP) Published:

Author / Expert

J Pediatr. 2020 Sep 17:S0022-3476(20)31130-6. doi: 10.1016/j.jpeds.2020.09.005. Online ahead of print. (Ziogas IA, Ye F, Zhao Z, Cao S, Rauf MA, Izzy M, Matsuoka LK, Gillis LA, Alexopoulos SP.- curated by SCHCP)

Topic overview

Objective: To determine risk factors for waitlist mortality in children with biliary atresia listed for liver transplantation.

Study design: 2,704 children with biliary atresia (<12 years) listed for first LT (2002-2018) in the United Network for Organ Sharing database were identified. Fine-Gray regression models for competing risks analysis (main risk=waitlist mortality/delisting due to too sick, competing risk=LT) were implemented to identify risk factors for waitlist mortality.

Results: The median waitlist time was 83 days (IQR: 34-191). The cumulative incidence of waitlist mortality was 5.2%. In multivariable analysis (n=2,253), increasing bilirubin level (p<.001), portal vein thrombosis (p=.03), and ventilator dependence (p<.001) at listing were associated with a higher risk, while weight ≥10 kg at listing (p=0.009) with a lower risk of waitlist mortality. When ascites at listing was included in multivariable analysis (n=1,376), it was associated with a higher risk for the composite outcome (p=.03). Encephalopathy at listing was not associated with waitlist mortality (n=1,376; P = .15).

Conclusions: These parameters can be utilized to more objectively prioritize children with BA awaiting LT and identify children with BA-related end-stage liver disease at high-risk of mortality.

DOI: 10.1016/j.jpeds.2020.09.005

Keywords

Hashtags

1 Views
0 Comments

Comments

Loading comments...